MedPath

Smoothies and Blood Sugars

Not Applicable
Recruiting
Conditions
Metabolic Disturbance
Interventions
Other: Food
Registration Number
NCT06333184
Lead Sponsor
University of Bath
Brief Summary

Glycaemic responses to fruit smoothies may depend on the food matrix (e.g., degree of processing and physical structure), ingestion rate, dose ingested and fibre content. Furthermore, the method of sampling could alter inferences. The aim of this project is to characterise how these factors affect the glycaemic response to a commercially available fruit smoothie. Participants will ingest 7 different test drinks in a randomised, crossover design with fingerstick capillary blood sampling alongside continuous glucose monitors. Test drinks will include a glucose reference (CONTROL), the commercial product matched for carbohydrate to CONTROL (PRODUCT), equivalent carbohydrate ingested as whole fruits (WHOLE), equivalent carbohydrate ingested as blended fruits (WHOLE), equivalent carbohydrate as the commercial product ingested slowly (SLOW), equivalent carbohydrate as the commercial product ingested with additional fibre (FIBRE), and the commercial product ingested in a dose typically bought (DOSE). These data will provide insight into how the food matrix and different patterns of ingestion can alter the glycaemic response to a fruit smoothie, and how the measurement method may alter interpretations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Age: 18-65 years
  • Body mass index 18-30 kg/m2
Exclusion Criteria
  • diagnosis of any form of diabetes
  • intolerances or allergies to any of the study procedures (e.g. fructose/inulin intolerance)
  • Fructose malabsorption
  • Inborn errors of fructose metabolism (e.g. fructokinase deficiency, aldolase B deficiency, fructose-1,6-bisphosphatase deficiency)
  • pregnant or lactating
  • any condition that could introduce bias to the study (e.g. diagnoses of lipid disorders, including cardiovascular disease, or therapies that alter lipid or glucose metabolism, such as statins or niacin).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ProductFood417 mL of commercially available "Mango \& Passion fruit" fruit smoothie providing 50 g carbohydrate
SlowFood417 mL of commercially available "Mango and Passionfruit" fruit smoothie providing 50 g carbohydrate ingested slowly over 25-35 mins.
ControlFood50 g glucose (55 g dextrose powder accounting for hydration) plus 417 mL water
WholeFoodApples (51%), Mango (16%), Banana (16%), Orange (12%), Passionfruit (3%), Peach (2%), Lime (0.4%; recipe matched to PRODUCT) eaten as whole fruit with added water as needed to match volume.
BlendFoodApples (51%), Mango (16%), Banana (16%), Orange (12%), Passionfruit (3%), Peach (2%), Lime (0.4%; recipe matched to PRODUCT) eaten as blended fruit with added water as needed to match volume.
FibreFood417 mL of commercially available "Mango and Passionfruit" fruit smoothie providing 50 g carbohydrate with 6 g of added inulin.
DoseFood250 mL of commercially available "Mango and Passionfruit" fruit smoothie providing 30 g carbohydrate.
Primary Outcome Measures
NameTimeMethod
Glycaemic index of product with capillary vs CGM120 min

The difference in glycaemic index \[2-hour incremental area under the curve (mmol/L-1x120 min) for PRODUCT relative to CONTROL expressed as a percentage\] in capillary blood samples versus continuous glucose monitors.

Secondary Outcome Measures
NameTimeMethod
Glycaemic index of all conditions with capillary vs CGM120 min

The difference in glycaemic index \[2-hour incremental area under the curve (mmol/L-1x120 min) for all other conditions (WHOLE, BLEND, SLOW, FIBRE, DOSE) relative to CONTROL expressed as a percentage\] in capillary blood samples versus continuous glucose monitors.

Trial Locations

Locations (1)

Department for Health, University of Bath

🇬🇧

Bath, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath